Reports
Desk Review of New Stuyahok Village
The objective of this desk review is to review New Stuyahok Village’s documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2022.
Audit of the Utilization of ARPA Information Technology Modernization Funds at the Railroad Retirement Board
Office on Violence Against Women's Administration Due to the COVID-19 Pandemic
The OIG is conducting an audit of the Office on Violence Against Women’s Grant Administration due to the COVID-19 Pandemic. The preliminary objectives are to assess: (1) the grant administration and monitoring during the pandemic and (2) the guidance and assistance provided to grant recipients for addressing any increased risks to effective program implementation and to violence against women.
Desk Review of Puerto Rico
The objective of this desk review is to evaluate Puerto Rico's documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds as reported in GrantSolutions and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through June 30, 2021.
Review of VHA’s Telehealth Billing Practices for Community Care during the COVID-19 Pandemic
Management advisory memorandum detailing the growth of community telehealth claims and the associated risks.
Disaster Preparedness of Federal Agencies
HUD OIG will summarize the conclusions/findings and recommendations reported by seven participating OIGs and the General Accountability Office related to natural disaster preparedness. Our objective is to inform Federal agencies and the OIG community of the reported conclusions/findings and recommendations regarding preparing for and responding to natural disasters.
Audit of the Coronavirus Relief Benefit Payments and Internal Controls
The preliminary objectives of this audit cover the extended unemployment and sickness benefits that were appropriated through the CARES Act, CARWA, and ARPA to determine if (1) they were accurately expended, recorded, and reported and (2) internal controls were effective, including fraud controls.
Comprehensive Healthcare Inspection Program (virtual reviews) Reports VISN 6 & 2
This report will provide (1) a descriptive evaluation of Veterans Integrated Service Network facilities’ pandemic readiness and response as determined by recent Comprehensive Healthcare Inspection Program inspections.
Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers
The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.
Yearend Review of Opioid Use in Medicare Part D in 2020
Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.